ArticleThoracic cancer2020

Treatment with or without bevacizumab as a first-line and maintenance therapy for advanced non-squamous non-small cell lung cancer: A retrospective study.

Ni Jun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.